* Eyenovia Inc EYEN.OQ reported a quarterly adjusted loss
of 11
cents per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -18 cents. The mean expectation of four analysts for the
quarter was for a loss of 13 cents per share. Wall Street
expected results to range from -18 cents to -10 cents per share.
* Revenue rose 66.7% to $2.00 thousand from a year ago;
analysts
expected $162.67 thousand.
* Eyenovia Inc's reported EPS for the quarter was a loss
of 11
cents.
* The company reported a quarterly loss of $7.89 million.
* Eyenovia Inc shares had fallen by 10.1% this quarter and
lost 77.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 4.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is "buy."
Wall Street's median 12-month price target for Eyenovia Inc is
$12.00
This summary was machine generated from LSEG data November 12 at
11:29 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.13 -0.11 Beat
Jun. 30 2024 -0.15 -0.21 Missed
Mar. 31 2024 -0.17 -0.23 Missed
Dec. 31 2023 -0.17 -0.18 Missed